CellR4 2020; 8: e2945
DOI: 10.32113/cellr4_202010_2945

Involvement of gut microbiota in solid organ transplantation

CellR4 2020; 8: e2939
DOI: 10.32113/cellr4_202010_2939

Mesenchymal stem cell-derived exosomes for the treatment of pulmonary diseases

CellR4 2020; 8: e2898
DOI: 10.32113/cellr4_20209_2898

The new antidiabetic agents: cardiovascular and renal protection in post-transplant diabetes mellitus

CellR4 2020; 8: e2896
DOI: 10.32113/cellr4_20209_2896

Mesenchymal stem cell-derived exosomes as drug delivery vehicles: an update

CellR4 2020; 8: e2894
DOI: 10.32113/cellr4_20209_2894

Advances in stem cell-based therapy for hair loss

CellR4 2020; 8: e2879
DOI: 10.32113/cellr4_20207_2879

Favorable effects of omega-3 PUFAs on glucose control in an adolescent with type 1 diabetes using continuous glucose monitoring: a case report

CellR4 2020; 8: e2877
DOI: 10.32113/cellr4_20207_2877

Adipose tissue browning for the treatment of obesity and metabolic diseases

CellR4 2020; 8: e2875
DOI: 10.32113/cellr4_20207_2875

Strategies to optimize glucose control during exercise in subjects with type 1 diabetes

CellR4 2020; 8: e2873
DOI: 10.32113/cellr4_20207_2873

Hyperconcentrated Platelet-Rich Plasma (High-PRP) for the treatment of a non-healing ulcer of the lateral malleolus: a case report and literature review

CellR4 2020; 8: e2846
DOI: 10.32113/cellr4_20205_2846

Editorial – Potential risks of the SARS-related coronavirus 2 infection [COVID-19] in pregnancy

CellR4 2020; 8: e2850
DOI: 10.32113/cellr4_20205_2850

Targeting Toll-Like Receptor 4: a promising strategy to prevent type 1 diabetes occurrence or recurrence

CellR4 2020; 8: e2852
DOI: 10.32113/cellr4_20205_2852

Challenges in managing immunosuppressive therapies for psoriasis during the COVID-19 pandemic

CellR4 2020; 8: e2854
DOI: 10.32113/cellr4_20205_2854

The impact of COVID-19 pandemic on pediatric oncology